Navigation Links
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
Date:11/5/2013

0%, to close at $4.70 per share. As of November 4, 2013, Ariad's stock was trading at $2.98 per share, down 85 percent from its trading value before October 8, 2013.

If you wish to discuss what rights you may have related to a loss in your investment in Ariad or you have any information on Ariad's representations about the Iclusig drug, please contact Eduardo Texidor Jr. at etexidor@cprlaw.com or, toll free, at 1-888-375-7600. For those investors inquiring via email, please include "Ariad" in the subject line, and, in the body of the email, the number of shares purchased and your mailing address and telephone number.

Since 1973, Cohen, Placitella & Roth, PC has been recognized as one of the premier trial law firms in the country. The firm has extensive experience in prosecuting securities litigation involving violations of the federal securities laws, state law derivative actions and mergers and acquisitions cases, representing institutional investors such as public pension plans and union pension funds as well as individual shareholders suffering substantial investment losses due to corporate misconduct. LexisNexis Martindale-Hubbell® annually reports Cohen, Placitella & Roth's peer rating-the highest AV® - "a testament to professional excellence." Since the inauguration of its "Best Law Firms"' edition in 2010, U.S. News and World Report has annually listed Cohen, Placitella & Roth as one of the top-tier class action law firms in the country.

Contact:
Eduardo Texidor Jr.
Cohen, Placitella & Roth, PC
Toll free: 1-888-375-7600
etexidor@cprlaw.com


'/>"/>
SOURCE Cohen, Placitella & Roth, PC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Upsher-Smith To Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures At 2013 American Epilepsy Society Meeting
2. UbiVac Opens Trial of Next Generation Lung Cancer Vaccine
3. Clinical Trial Indicates Gabapentin Is Safe and Effective for Treating Alcohol Dependence
4. Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients
5. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. EntreMed Commences Phase 2 Trial For ENMD-2076 In Ovarian Clear Cell Carcinomas
7. Soterix Medical Inc. announces Phase 3 Clinical Trial for Depression comparing tDCS-LTE against antidepressant drug (Escitalopram)
8. Langland Collaboration with CISCRP to Show Participants How Their Words Can Impact a Clinical Trial
9. InspireMD Schedules Conference Call to Discuss MASTER Trial 12-month Follow-Up Data
10. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
11. French Cost-Effectiveness Trial of PneumRx RePneu LVR Coil Fully Enrolled in Record Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... FORT WORTH, Texas , May 5, 2015 /PRNewswire/ ... market was valued at $94.9 million in 2014, and ... at a CAGR of 7.8% from 2014 to 2019. ... Ophthalmology Glaucoma Surgery Device Market for an analysis of ... tables and figures. http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html ...
(Date:5/5/2015)... ST. LOUIS and NIJMEGEN, ... -- EndoStim, a medical device company developing lower ... disease (GERD) announced long-term, 3-year, positive safety and ... of reflux symptoms of both heartburn and regurgitation ... 24-hour esophageal pH test) with near-complete elimination of ...
(Date:5/5/2015)... LONG BEACH, Calif. and ST. ... with diabetes, high blood pressure or high cholesterol may ... part of performance-based networks, according to early results of ... Express Scripts (NASDAQ: ESRX ). "Pharmacists ... professionals and their frequent interactions with our members presents ...
Breaking Medicine Technology:North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 4
... Data from a pivotal trial suggests that ofatumumab has ... treatments , , ... and Genmab A/S (OMX: GEN) announced today positive results ... (ofatumumab) in the treatment of refractory chronic lymphocytic leukemia ...
... Alexion Pharmaceuticals,Inc. (Nasdaq: ALXN ) ... open-label,registration study examining Soliris(R) (eculizumab) treatment of ... pre-specified,primary efficacy endpoint of change in hemolysis ... Key secondary endpoints including fatigue,(P<0.001) and transfusions/anemia ...
Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 2Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 3Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 4Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 5Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 6Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 7Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH 8
(Date:5/5/2015)... May 05, 2015 AxoGen, Inc. ... on the $1.6 billion peripheral nerve repair market, reported ... ended March 31, 2015 compared to $3.14 million in ... adoption of our proprietary portfolio of nerve repair products ... AxoGuard® Nerve Protector – and our solid sales execution ...
(Date:5/5/2015)... May 05, 2015 The 2015 Crystal Ball, ... to benefit their global research, outreach and patient advocacy programs. ... and awards ceremony that attracted hundreds of supporters. , The ... discovery of the hepatitis B virus (HBV) by Dr. Baruch ... the Nobel Prize in Medicine for his discovery of the ...
(Date:5/5/2015)... Fla. (PRWEB) May 05, 2015 Baptist ... the Commission on Cancer (CoC) of the American College ... cancer program must meet more than 30 Commission on ... through a survey process, and maintain levels of excellence ... , When patients choose to seek care locally at ...
(Date:5/5/2015)... May 05, 2015 " QuickPick Travel ” ... Report, which takes a look small, medium, and large businesses ... for NewsWatch and a business expert, conducted the business review ... to plan up to three weeks of vacation for free. ... and friends, and explore the world. And when people are ...
(Date:5/5/2015)... ProTexting, LLC – a premier SMS ... Engagement Campaigns and other Mobile solutions, introduces e-mail integration ... leverage the power of Mobile Marketing to expand their ... addresses into the Constant Contact Platform. , ProTexting CEO, ... trend of multi-channel marketing would become more prominent in ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... People are more likely to disapprove of and avoid substance ... a new study. Participants were presented with six fictitious ... alcohol or drugs, smoked, or was obese. "Specifically, participants ... to marry into their family, be friends, socialize, work on ...
... from Loyola University Chicago Stritch School of Medicine ... selected for prestigious Schweitzer Fellowships. Michelle Leahy, Ray ... to design and implement innovative, yearlong projects to ... well-being. Named in honor of famed humanitarian ...
... Cardinal Bernardin Cancer Center has received an Outstanding Achievement ... College of Surgeons. The award is given to ... rating in each of seven standards. The centers were ... areas of cancer program activity: cancer committee leadership, cancer ...
... -- Receiving emotional support and acceptance from parents benefits ... a new study shows. About three-quarters of lesbian, ... in Massachusetts said they had revealed their sexual orientation ... years old. About two-thirds said their parents were supportive. ...
... Reporter , FRIDAY, April 13 (HealthDay News) -- Obese and ... more radiation than people of normal weight, researchers say. ... is needed to scan their bodies, a radiation specialist said. ... size, increase the power of the X-rays and the quantity ...
... April 13 (HealthDay News) -- The physical architecture of intelligence ... brain injury patients to conduct their research. The findings ... general intelligence and specific skills such as memory and the ... War veterans who had highly localized brain damage caused by ...
Cached Medicine News:Health News:Loyola Stritch, Niehoff students receive prestigious Schweitzer Fellowships 2Health News:Gay Adults Rejected by Parents Have Worse Health, Study Finds 2Health News:CT Scans Deliver More Radiation to Obese People: Study 2Health News:Researchers Map Brain Regions Linked to Intelligence 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: